Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19
Rainer Kaiser, … , Leo Nicolai, Konstantin Stark
Rainer Kaiser, … , Leo Nicolai, Konstantin Stark
Published August 17, 2021
Citation Information: JCI Insight. 2021;6(18):e150862. https://doi.org/10.1172/jci.insight.150862.
View: Text | PDF
Research Article COVID-19 Vascular biology

Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19

  • Text
  • PDF
Abstract

Neutrophils provide a critical line of defense in immune responses to various pathogens, inflicting self-damage upon transition to a hyperactivated, procoagulant state. Recent work has highlighted proinflammatory neutrophil phenotypes contributing to lung injury and acute respiratory distress syndrome (ARDS) in patients with coronavirus disease 2019 (COVID-19). Here, we use state-of-the art mass spectrometry–based proteomics and transcriptomic and correlative analyses as well as functional in vitro and in vivo studies to dissect how neutrophils contribute to the progression to severe COVID-19. We identify a reinforcing loop of both systemic and neutrophil intrinsic IL-8 (CXCL8/IL-8) dysregulation, which initiates and perpetuates neutrophil-driven immunopathology. This positive feedback loop of systemic and neutrophil autocrine IL-8 production leads to an activated, prothrombotic neutrophil phenotype characterized by degranulation and neutrophil extracellular trap (NET) formation. In severe COVID-19, neutrophils directly initiate the coagulation and complement cascade, highlighting a link to the immunothrombotic state observed in these patients. Targeting the IL-8–CXCR-1/-2 axis interferes with this vicious cycle and attenuates neutrophil activation, degranulation, NETosis, and IL-8 release. Finally, we show that blocking IL-8–like signaling reduces severe acute respiratory distress syndrome of coronavirus 2 (SARS-CoV-2) spike protein–induced, human ACE2–dependent pulmonary microthrombosis in mice. In summary, our data provide comprehensive insights into the activation mechanisms of neutrophils in COVID-19 and uncover a self-sustaining neutrophil–IL-8 axis as a promising therapeutic target in severe SARS-CoV-2 infection.

Authors

Rainer Kaiser, Alexander Leunig, Kami Pekayvaz, Oliver Popp, Markus Joppich, Vivien Polewka, Raphael Escaig, Afra Anjum, Marie-Louise Hoffknecht, Christoph Gold, Sophia Brambs, Anouk Engel, Sven Stockhausen, Viktoria Knottenberg, Anna Titova, Mohamed Haji, Clemens Scherer, Maximilian Muenchhoff, Johannes C. Hellmuth, Kathrin Saar, Benjamin Schubert, Anne Hilgendorff, Christian Schulz, Stefan Kääb, Ralf Zimmer, Norbert Hübner, Steffen Massberg, Philipp Mertins, Leo Nicolai, Konstantin Stark

×

Figure 2

Severe COVID-19 neutrophils upregulate proteins implicated in IL-8 signaling.

Options: View larger image (or click on image) Download as PowerPoint
Severe COVID-19 neutrophils upregulate proteins implicated in IL-8 signa...
(A) ClueGo upregulated neutrophil proteome pathway grouping of severe COVID-19 compared with intermediate COVID-19. (B) Heatmap of mean IL-8 pathway protein abundance on neutrophils by group. (C) Box plot of IL-8 score calculated from log-scaled abundance values (see methods) by group. One-way ANOVA with post hoc Tukey’s multiple comparisons test between all groups. (A–C) n = 9 healthy control, n = 5 pneumonic control, n = 5 severe COVID-19 and n = 9 intermediate patients with COVID-19. (D and E) Linear regression of Horowitz index (PaO2/FiO2) or clinically measured D-dimer (μg/mL) and IL-8 score of patients with COVID-19. P value signifies slope significantly non-zero. 95% confidence interval shown in gray. n = 5 severe and 9 intermediate patients with COVID-19. (F) Box plot of normalized serum IL-8 plasma levels of COVID-19 and control patients. n = 26 control patients without COVID-19, n = 78 patients with mild-moderate COVID-19 (WHO Grade 1–4), n = 29 severe COVID-19 (WHO Grade 5–8) patients. One-way ANOVA with post hoc Tukey’s multiple comparisons test. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts